{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T10:22:03Z","timestamp":1789035723601,"version":"build-2803163510"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,25]]},"DOI":"10.7759\/cureus.82991","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T16:57:36Z","timestamp":1745600256000},"source":"Crossref","is-referenced-by-count":5,"title":["Comprehensive Review on Hair Loss and Restorative Techniques: Advances in Diagnostic, Artistry, and Surgical Innovation"],"prefix":"10.7759","author":[{"given":"Luis A","family":"Mendoza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genaro G","family":"Ocampo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yozahandy A","family":"Abarca-Pineda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mubashir","family":"Ahmad Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najaee","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denyse","family":"Deowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Nazir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/ski2.194","article-title":"A catena between psychiatric disorders and non-scarring alopecias--a systematic review","volume":"3","author":"Forneris Crego AL","year":"2023","unstructured":"Forneris Crego AL, Therianou A, Hashemi P, Higgins CA. A catena between psychiatric disorders and non-scarring alopecias--a systematic review. Skin Health Dis. 2023, 3:e194. 10.1002\/ski2.194","journal-title":"Skin Health Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2017.09.008","article-title":"Advances in hair restoration","volume":"36","author":"Rose PT","year":"2018","unstructured":"Rose PT. Advances in hair restoration. Dermatol Clin. 2018, 36:57-62. 10.1016\/j.det.2017.09.008","journal-title":"Dermatol Clin"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.05.040","article-title":"Approach to the patient with hair loss","volume":"89","author":"Workman K","year":"2023","unstructured":"Workman K, Piliang M. Approach to the patient with hair loss. J Am Acad Dermatol. 2023, 89:S3-8. 10.1016\/j.jaad.2023.05.040","journal-title":"J Am Acad Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2021.03.003","article-title":"New diagnostic tools to evaluate hair loss","volume":"39","author":"Kurtti A","year":"2021","unstructured":"Kurtti A, Jagdeo J, Eisinger A, Sukhdeo K. New diagnostic tools to evaluate hair loss. Dermatol Clin. 2021, 39:375-81. 10.1016\/j.det.2021.03.003","journal-title":"Dermatol Clin"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.05.004","article-title":"Medical and procedural treatment of androgenetic alopecia - where are we?","volume":"89","author":"Ly NY","year":"2023","unstructured":"Ly NY, Fruechte S, Hordinsky MK, Sadick N, Arruda S, Farah RS. Medical and procedural treatment of androgenetic alopecia - where are we?. J Am Acad Dermatol. 2023, 89:S36-9. 10.1016\/j.jaad.2023.05.004","journal-title":"J Am Acad Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/med\/9780190499075.003.0026","article-title":"Advances in hair transplantation","author":"Evans GRD","year":"2019","unstructured":"Evans GRD, Barrera A. Advances in hair transplantation. Operative Plastic Surgery. Evans G (ed): Oxford Academic, New York; 2019. 10.1093\/med\/9780190499075.003.0026"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.25122\/jml-2024-0303","article-title":"Stem cell therapy prior to follicular unit hair transplantation on scarred tissue: a novel approach to a successful procedure","volume":"17","author":"Popescu FM","year":"2024","unstructured":"Popescu FM, Filip L, Popescu M, Florescu IP. Stem cell therapy prior to follicular unit hair transplantation on scarred tissue: a novel approach to a successful procedure. J Med Life. 2024, 17:582-7. 10.25122\/jml-2024-0303","journal-title":"J Med Life"},{"key":"ref8","article-title":"Lichen Planopilaris","author":"Lepe K","year":"2024","unstructured":"Lepe K, Nassereddin A, Syed HA, Salazar FJ. Lichen Planopilaris. StatPearls [Internet], Treasure Island (FL); 2024."},{"key":"ref9","article-title":"Histology, Hair and Follicle","author":"Brown TM","year":"2024","unstructured":"Brown TM, Krishnamurthy K. Histology, Hair and Follicle. StatPearls [Internet], Treasure Island (FL); 2024."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000037300","article-title":"Interleukin gene polymorphisms and alopecia areata: a systematic review and meta-analysis","volume":"103","author":"Tishe ZH","year":"2024","unstructured":"Tishe ZH, Shawkat S, Popy MN, Ahmed A, Mumu SB, Apu MN, Mostaid MS. Interleukin gene polymorphisms and alopecia areata: a systematic review and meta-analysis. Medicine (Baltimore). 2024, 103:e37300. 10.1097\/MD.0000000000037300","journal-title":"Medicine (Baltimore)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.01.056","article-title":"Primary cicatricial alopecia: other lymphocytic primary cicatricial alopecias and neutrophilic and mixed primary cicatricial alopecias","volume":"75","author":"Bolduc C","year":"2016","unstructured":"Bolduc C, Sperling LC, Shapiro J. Primary cicatricial alopecia: other lymphocytic primary cicatricial alopecias and neutrophilic and mixed primary cicatricial alopecias. J Am Acad Dermatol. 2016, 75:1101-17. 10.1016\/j.jaad.2015.01.056","journal-title":"J Am Acad Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.09.058","article-title":"Primary cicatricial alopecia: Lymphocytic primary cicatricial alopecias, including chronic cutaneous lupus erythematosus, lichen planopilaris, frontal fibrosing alopecia, and Graham-Little syndrome","volume":"75","author":"Bolduc C","year":"2016","unstructured":"Bolduc C, Sperling LC, Shapiro J. Primary cicatricial alopecia: Lymphocytic primary cicatricial alopecias, including chronic cutaneous lupus erythematosus, lichen planopilaris, frontal fibrosing alopecia, and Graham-Little syndrome. J Am Acad Dermatol. 2016, 75:1081-99. 10.1016\/j.jaad.2014.09.058","journal-title":"J Am Acad Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12093259","article-title":"Recent advances in understanding of the etiopathogenesis, diagnosis, and management of hair loss diseases","volume":"12","author":"Kinoshita-Ise M","year":"2023","unstructured":"Kinoshita-Ise M, Fukuyama M, Ohyama M. Recent advances in understanding of the etiopathogenesis, diagnosis, and management of hair loss diseases. J Clin Med. 2023, 12:3259. 10.3390\/jcm12093259","journal-title":"J Clin Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ad.2022.12.003","article-title":"Trichoscopy: an update [Article in Spanish]","volume":"114","author":"Fern\u00e1ndez-Domper L","year":"2023","unstructured":"Fern\u00e1ndez-Domper L, Ballesteros-Redondo M, Va\u00f1\u00f3-Galv\u00e1n S. Trichoscopy: an update [Article in Spanish]. Actas Dermosifiliogr. 2023, 114:327-33. 10.1016\/j.ad.2022.12.003","journal-title":"Actas Dermosifiliogr"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.04.033","article-title":"The dermatoscope in the hair clinic: trichoscopy of scarring and nonscarring alopecia","volume":"89","author":"Pirmez R","year":"2023","unstructured":"Pirmez R. The dermatoscope in the hair clinic: trichoscopy of scarring and nonscarring alopecia. J Am Acad Dermatol. 2023, 89:S9-S15. 10.1016\/j.jaad.2023.04.033","journal-title":"J Am Acad Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.reth.2022.10.005","article-title":"Regenerative medicine strategies for hair growth and regeneration: a narrative review of literature","volume":"21","author":"Shimizu Y","year":"2022","unstructured":"Shimizu Y, Ntege EH, Sunami H, Inoue Y. Regenerative medicine strategies for hair growth and regeneration: a narrative review of literature. Regen Ther. 2022, 21:527-39. 10.1016\/j.reth.2022.10.005","journal-title":"Regen Ther"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19318","article-title":"Alopecia areata is associated with increased genetic risk of myocardial infarction: a Mendelian randomization study","volume":"37","author":"O'Hagan R","year":"2023","unstructured":"O'Hagan R, Caldas SA, Correa da Rosa JM, Guttman-Yassky E, Ungar B. Alopecia areata is associated with increased genetic risk of myocardial infarction: a Mendelian randomization study. J Eur Acad Dermatol Venereol. 2023, 37:e1341-3. 10.1111\/jdv.19318","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2340\/actadv.v104.39982","article-title":"Sex-related variations in comorbidities in lichen sclerosus: a systematic review and meta-analysis","volume":"104","author":"\u0160uler Baglama \u0160","year":"2024","unstructured":"\u0160uler Baglama \u0160, Jemec GB, Zmazek J, Tr\u010dko K. Sex-related variations in comorbidities in lichen sclerosus: a systematic review and meta-analysis. Acta Derm Venereol. 2024, 104:adv39982. 10.2340\/actadv.v104.39982","journal-title":"Acta Derm Venereol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.11.027","article-title":"The comparison of demographics and comorbidities of female pattern hair loss according to the clinical subtype and stage","volume":"87","author":"\u00d6zkoca D","year":"2022","unstructured":"\u00d6zkoca D, A\u015fk\u0131n \u00d6, Engin B. The comparison of demographics and comorbidities of female pattern hair loss according to the clinical subtype and stage. J Am Acad Dermatol. 2022, 87:779-83. 10.1016\/j.jaad.2021.11.027","journal-title":"J Am Acad Dermatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1590\/s0365-05962012000300010","article-title":"Hair loss perception and symptoms of depression in female outpatients attending a general dermatology clinic","volume":"87","author":"Schmitt JV","year":"2012","unstructured":"Schmitt JV, Ribeiro CF, Souza FH, Siqueira EB, Bebber FR. Hair loss perception and symptoms of depression in female outpatients attending a general dermatology clinic. An Bras Dermatol. 2012, 87:412-7. 10.1590\/s0365-05962012000300010","journal-title":"An Bras Dermatol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.2340\/actadv.v101.1012","article-title":"Systematic review and meta-analysis of the association between metabolic syndrome and androgenetic alopecia","volume":"102","author":"Qiu Y","year":"2022","unstructured":"Qiu Y, Zhou X, Fu S, Luo S, Li Y. Systematic review and meta-analysis of the association between metabolic syndrome and androgenetic alopecia. Acta Derm Venereol. 2022, 102:adv00645. 10.2340\/actadv.v101.1012","journal-title":"Acta Derm Venereol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14811","article-title":"How good is artificial intelligence (AI) at solving hairy problems? A review of AI applications in hair restoration and hair disorders","volume":"34","author":"Gupta AK","year":"2021","unstructured":"Gupta AK, Ivanova IA, Renaud HJ. How good is artificial intelligence (AI) at solving hairy problems? A review of AI applications in hair restoration and hair disorders. Dermatol Ther. 2021, 34:e14811. 10.1111\/dth.14811","journal-title":"Dermatol Ther"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.procs.2018.05.157","article-title":"Automated classification method for early diagnosis of alopecia using machine learning","volume":"132","author":"Kapoor I","year":"2018","unstructured":"Kapoor I, Mishra A. Automated classification method for early diagnosis of alopecia using machine learning. Procedia Comput Sci. 2018, 132:437-43. 10.1016\/j.procs.2018.05.157","journal-title":"Procedia Comput Sci"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdin.2024.04.003","article-title":"Using artificial intelligence to compute Severity of Alopecia tool scores","volume":"18","author":"Nguyen H","year":"2025","unstructured":"Nguyen H, Gazeau L, Wolfe J. Using artificial intelligence to compute Severity of Alopecia tool scores. JAAD Int. 2025, 18:101-2. 10.1016\/j.jdin.2024.04.003","journal-title":"JAAD Int"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.2174\/187221312800166859","article-title":"Minoxidil use in dermatology, side effects and recent patents","volume":"6","author":"Rossi A","year":"2012","unstructured":"Rossi A, Cantisani C, Melis L, Iorio A, Scali E, Calvieri S. Minoxidil use in dermatology, side effects and recent patents. Recent Pat Inflamm Allergy Drug Discov. 2012, 6:130-6. 10.2174\/187221312800166859","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1159\/000248899","article-title":"Immunohistochemical characterization of the cellular infiltrate in severe alopecia areata before and after minoxidil treatment","volume":"175","author":"Fiedler VC","year":"1987","unstructured":"Fiedler VC, Buys CM. Immunohistochemical characterization of the cellular infiltrate in severe alopecia areata before and after minoxidil treatment. Dermatologica. 1987, 175:29-35. 10.1159\/000248899","journal-title":"Dermatologica"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S214907","article-title":"Minoxidil and its use in hair disorders: a review","volume":"13","author":"Suchonwanit P","year":"2019","unstructured":"Suchonwanit P, Thammarucha S, Leerunyakul K. Minoxidil and its use in hair disorders: a review. Drug Des Devel Ther. 2019, 13:2777-86. 10.2147\/DDDT.S214907","journal-title":"Drug Des Devel Ther"},{"key":"ref28","article-title":"The efficacy of topical minoxidil for non-scarring alopecia: a systematic review","volume":"18","author":"Sung CT","year":"2019","unstructured":"Sung CT, Juhasz ML, Choi FD, Mesinkovska NA. The efficacy of topical minoxidil for non-scarring alopecia: a systematic review. J Drugs Dermatol. 2019, 18:155-60.","journal-title":"J Drugs Dermatol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2020.1749547","article-title":"Efficacy of non-surgical treatments for androgenetic alopecia in men and women: a systematic review with network meta-analyses, and an assessment of evidence quality","author":"Gupta AK","year":"2022","unstructured":"Gupta AK, Bamimore MA, Foley KA. Efficacy of non-surgical treatments for androgenetic alopecia in men and women: a systematic review with network meta-analyses, and an assessment of evidence quality. J Dermatolog Treat. 2022, 33:62-72. Accessed: December 17, 2024: https:\/\/www.tandfonline.com\/doi\/abs\/10.1080\/09546634.2020.1749547. 10.1080\/09546634.2020.1749547"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.124088","article-title":"A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men","volume":"47","author":"Olsen EA","year":"2002","unstructured":"Olsen EA, Dunlap FE, Funicella T, Koperski JA, Swinehart JM, Tschen EH, Trancik RJ. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2002, 47:377-85. 10.1067\/mjd.2002.124088","journal-title":"J Am Acad Dermatol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2003.06.014","article-title":"A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss","volume":"50","author":"Lucky AW","year":"2004","unstructured":"Lucky AW, Piacquadio DJ, Ditre CM, et al.. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. J Am Acad Dermatol. 2004, 50:541-53. 10.1016\/j.jaad.2003.06.014","journal-title":"J Am Acad Dermatol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.119104","article-title":"Allergic contact dermatitis to topical minoxidil solution: etiology and treatment","volume":"46","author":"Friedman ES","year":"2002","unstructured":"Friedman ES, Friedman PM, Cohen DE, Washenik K. Allergic contact dermatitis to topical minoxidil solution: etiology and treatment. J Am Acad Dermatol. 2002, 46:309-12. 10.1067\/mjd.2002.119104","journal-title":"J Am Acad Dermatol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.4103\/0974-7753.171587","article-title":"Generalized hypertrichosis induced by topical minoxidil in an adult woman","volume":"7","author":"Chellini PR","year":"2015","unstructured":"Chellini PR, Pirmez R, Raso P, Sodr\u00e9 CT. Generalized hypertrichosis induced by topical minoxidil in an adult woman. Int J Trichology. 2015, 7:182-3. 10.4103\/0974-7753.171587","journal-title":"Int J Trichology"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-022-00730-y","article-title":"What\u2019s new in therapy for male androgenetic alopecia?","volume":"24","author":"Saceda-Corralo D","year":"2023","unstructured":"Saceda-Corralo D, Dom\u00ednguez-Santas M, Va\u00f1\u00f3-Galv\u00e1n S, Grimalt R. What\u2019s new in therapy for male androgenetic alopecia?. Am J Clin Dermatol. 2023, 24:15-24. 10.1007\/s40257-022-00730-y","journal-title":"Am J Clin Dermatol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.06.1009","article-title":"Oral minoxidil treatment for hair loss: a review of efficacy and safety","volume":"84","author":"Randolph M","year":"2021","unstructured":"Randolph M, Tosti A. Oral minoxidil treatment for hair loss: a review of efficacy and safety. J Am Acad Dermatol. 2021, 84:737-46. 10.1016\/j.jaad.2020.06.1009","journal-title":"J Am Acad Dermatol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.14933","article-title":"Low-dose oral minoxidil as treatment for non-scarring alopecia: a systematic review","volume":"59","author":"Sharma AN","year":"2020","unstructured":"Sharma AN, Michelle L, Juhasz M, Muller Ramos P, Atanaskova Mesinkovska N. Low-dose oral minoxidil as treatment for non-scarring alopecia: a systematic review. Int J Dermatol. 2020, 59:1013-9. 10.1111\/ijd.14933","journal-title":"Int J Dermatol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17216","article-title":"Review of oral minoxidil as treatment of hair disorders: in search of the perfect dose","volume":"35","author":"Villani A","year":"2021","unstructured":"Villani A, Fabbrocini G, Ocampo-Candiani J, Ruggiero A, Ocampo-Garza SS. Review of oral minoxidil as treatment of hair disorders: in search of the perfect dose. J Eur Acad Dermatol Venereol. 2021, 35:1485-92. 10.1111\/jdv.17216","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14106","article-title":"Safety of low-dose oral minoxidil treatment for hair loss. A systematic review and pooled-analysis of individual patient data","volume":"33","author":"Jimenez-Cauhe J","year":"2020","unstructured":"Jimenez-Cauhe J, Saceda-Corralo D, Rodrigues-Barata R, et al.. Safety of low-dose oral minoxidil treatment for hair loss. A systematic review and pooled-analysis of individual patient data. Dermatol Ther. 2020, 33:e14106. 10.1111\/dth.14106","journal-title":"Dermatol Ther"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2024.0284","article-title":"Oral minoxidil vs topical minoxidil for male androgenetic alopecia: a randomized clinical trial","volume":"160","author":"Penha MA","year":"2024","unstructured":"Penha MA, Miot HA, Kasprzak M, M\u00fcller Ramos P. Oral minoxidil vs topical minoxidil for male androgenetic alopecia: a randomized clinical trial. JAMA Dermatol. 2024, 160:600-5. 10.1001\/jamadermatol.2024.0284","journal-title":"JAMA Dermatol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.17524","article-title":"Efficacy and safety of oral minoxidil versus topical solution in androgenetic alopecia: a meta-analysis of randomized clinical trials","volume":"64","author":"Sobral MV","year":"2025","unstructured":"Sobral MV, Moreira JL, Rodrigues LK, et al.. Efficacy and safety of oral minoxidil versus topical solution in androgenetic alopecia: a meta-analysis of randomized clinical trials. Int J Dermatol. 2025, 64:479-84. 10.1111\/ijd.17524","journal-title":"Int J Dermatol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2020.1721463","article-title":"A review of the treatment of male pattern hair loss","volume":"21","author":"York K","year":"2020","unstructured":"York K, Meah N, Bhoyrul B, Sinclair R. A review of the treatment of male pattern hair loss. Expert Opin Pharmacother. 2020, 21:603-12. 10.1080\/14656566.2020.1721463","journal-title":"Expert Opin Pharmacother"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-014-0077-5","article-title":"Androgenetic alopecia: an evidence-based treatment update","volume":"15","author":"Varothai S","year":"2014","unstructured":"Varothai S, Bergfeld WF. Androgenetic alopecia: an evidence-based treatment update. Am J Clin Dermatol. 2014, 15:217-30. 10.1007\/s40257-014-0077-5","journal-title":"Am J Clin Dermatol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.3109\/09546634.2013.813011","article-title":"The efficacy and safety of 5\u03b1-reductase inhibitors in androgenetic alopecia: a network meta-analysis and benefit-risk assessment of finasteride and dutasteride","volume":"25","author":"Gupta AK","year":"2014","unstructured":"Gupta AK, Charrette A. The efficacy and safety of 5\u03b1-reductase inhibitors in androgenetic alopecia: a network meta-analysis and benefit-risk assessment of finasteride and dutasteride. J Dermatolog Treat. 2014, 25:156-61. 10.3109\/09546634.2013.813011","journal-title":"J Dermatolog Treat"},{"key":"ref44","article-title":"A systematic review of topical finasteride in the treatment of androgenetic alopecia in men and women","volume":"17","author":"Lee SW","year":"2018","unstructured":"Lee SW, Juhasz M, Mobasher P, Ekelem C, Mesinkovska NA. A systematic review of topical finasteride in the treatment of androgenetic alopecia in men and women. J Drugs Dermatol. 2018, 17:457-63.","journal-title":"J Drugs Dermatol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S385861","article-title":"Treatment of androgenetic alopecia: current guidance and unmet needs","volume":"16","author":"Kaiser M","year":"2023","unstructured":"Kaiser M, Abdin R, Gaumond SI, Issa NT, Jimenez JJ. Treatment of androgenetic alopecia: current guidance and unmet needs. Clin Cosmet Investig Dermatol. 2023, 16:1387-406. 10.2147\/CCID.S385861","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13059","article-title":"Physiopathology and current treatments of androgenetic alopecia: going beyond androgens and anti-androgens","volume":"32","author":"Katzer T","year":"2019","unstructured":"Katzer T, Leite Junior A, Beck R, da Silva C. Physiopathology and current treatments of androgenetic alopecia: going beyond androgens and anti-androgens. Dermatol Ther. 2019, 32:e13059. 10.1111\/dth.13059","journal-title":"Dermatol Ther"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.905140","article-title":"Efficacy and safety of 5% minoxidil alone, minoxidil plus oral spironolactone, and minoxidil plus microneedling on female pattern hair loss: a prospective, single-center, parallel-group, evaluator blinded, randomized trial","volume":"9","author":"Liang X","year":"2022","unstructured":"Liang X, Chang Y, Wu H, Liu Y, Zhao J, Wang L, Zhuo F. Efficacy and safety of 5% minoxidil alone, minoxidil plus oral spironolactone, and minoxidil plus microneedling on female pattern hair loss: a prospective, single-center, parallel-group, evaluator blinded, randomized trial. Front Med (Lausanne). 2022, 9:905140. 10.3389\/fmed.2022.905140","journal-title":"Front Med (Lausanne)"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-023-01880-x","article-title":"Androgenetic alopecia: therapy update","volume":"83","author":"Devjani S","year":"2023","unstructured":"Devjani S, Ezemma O, Kelley KJ, Stratton E, Senna M. Androgenetic alopecia: therapy update. Drugs. 2023, 83:701-15. 10.1007\/s40265-023-01880-x","journal-title":"Drugs"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1P600","article-title":"Prospective cohort study on the effects and tolerability of flutamide in patients with female pattern hair loss","volume":"45","author":"Paradisi R","year":"2011","unstructured":"Paradisi R, Porcu E, Fabbri R, Seracchioli R, Battaglia C, Venturoli S. Prospective cohort study on the effects and tolerability of flutamide in patients with female pattern hair loss. Ann Pharmacother. 2011, 45:469-75. 10.1345\/aph.1P600","journal-title":"Ann Pharmacother"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13096","article-title":"Oral bicalutamide for female pattern hair loss: a pilot study","volume":"32","author":"Fernandez-Nieto D","year":"2019","unstructured":"Fernandez-Nieto D, Saceda-Corralo D, Rodrigues-Barata R, et al.. Oral bicalutamide for female pattern hair loss: a pilot study. Dermatol Ther. 2019, 32:e13096. 10.1111\/dth.13096","journal-title":"Dermatol Ther"},{"key":"ref51","article-title":"Systemic cyproterone acetate and 5% minoxidil topical in the treatment of female pattern hair loss","volume":"19","author":"Kapadia N","year":"2009","unstructured":"Kapadia N, Borhany T, Khalid G, Fatima A. Systemic cyproterone acetate and 5% minoxidil topical in the treatment of female pattern hair loss. J Pak Assoc Dermatol. 2009, 19:216-9.","journal-title":"J Pak Assoc Dermatol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1111\/ced.14292","article-title":"Clascoterone as a novel treatment for androgenetic alopecia","volume":"45","author":"Sun HY","year":"2020","unstructured":"Sun HY, Sebaratnam DF. Clascoterone as a novel treatment for androgenetic alopecia. Clin Exp Dermatol. 2020, 45:913-4. 10.1111\/ced.14292","journal-title":"Clin Exp Dermatol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.89776","article-title":"Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata","volume":"1","author":"Kennedy Crispin M","year":"2016","unstructured":"Kennedy Crispin M, Ko JM, Craiglow BG, et al.. Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata. JCI Insight. 2016, 1:e89776. 10.1172\/jci.insight.89776","journal-title":"JCI Insight"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.89790","article-title":"Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata","volume":"1","author":"Mackay-Wiggan J","year":"2016","unstructured":"Mackay-Wiggan J, Jabbari A, Nguyen N, et al.. Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata. JCI Insight. 2016, 1:e89790. 10.1172\/jci.insight.89790","journal-title":"JCI Insight"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2015.02.015","article-title":"Reversal of alopecia areata following treatment with the JAK1\/2 inhibitor baricitinib","volume":"2","author":"Jabbari A","year":"2015","unstructured":"Jabbari A, Dai Z, Xing L, et al.. Reversal of alopecia areata following treatment with the JAK1\/2 inhibitor baricitinib. EBioMedicine. 2015, 2:351-5. 10.1016\/j.ebiom.2015.02.015","journal-title":"EBioMedicine"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.33590\/emjdermatol\/WSNX3627","article-title":"The advances in treatment options for conditions causing hair loss","volume":"12","author":"Kaufman L","year":"2024","unstructured":"Kaufman L, Dulmage B. The advances in treatment options for conditions causing hair loss. EMJ Dermatol. 2024, 12:117-121. 10.33590\/emjdermatol\/WSNX3627","journal-title":"EMJ Dermatol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-021-08883-0","article-title":"Alopecia areata: an update on etiopathogenesis, diagnosis, and management","volume":"61","author":"Zhou C","year":"2021","unstructured":"Zhou C, Li X, Wang C, Zhang J. Alopecia areata: an update on etiopathogenesis, diagnosis, and management. Clin Rev Allergy Immunol. 2021, 61:403-23. 10.1007\/s12016-021-08883-0","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1096\/fj.12-218156","article-title":"The prostamide-related glaucoma therapy, bimatoprost, offers a novel approach for treating scalp alopecias","volume":"27","author":"Khidhir KG","year":"2013","unstructured":"Khidhir KG, Woodward DF, Farjo NP, et al.. The prostamide-related glaucoma therapy, bimatoprost, offers a novel approach for treating scalp alopecias. FASEB J. 2013, 27:557-67. 10.1096\/fj.12-218156","journal-title":"FASEB J"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3003122","article-title":"Prostaglandin D2 inhibits hair growth and is elevated in bald scalp of men with androgenetic alopecia","volume":"4","author":"Garza LA","year":"2012","unstructured":"Garza LA, Liu Y, Yang Z, et al.. Prostaglandin D2 inhibits hair growth and is elevated in bald scalp of men with androgenetic alopecia. Sci Transl Med. 2012, 4:126ra34. 10.1126\/scitranslmed.3003122","journal-title":"Sci Transl Med"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.5455\/IJMRCR.TopicalBimatoprost-androgenic-alopecia","article-title":"The effect of topical bimatoprost 0.03% solution on androgenic alopecia","volume":"2","author":"Aryaningrum D","year":"2018","unstructured":"Aryaningrum D, Adriani A, Anwar AI, Tabri F, Bahar B, Massi N. The effect of topical bimatoprost 0.03% solution on androgenic alopecia. Int J Med Rev Case Rep. 2018, 2:166-8. 10.5455\/IJMRCR.TopicalBimatoprost-androgenic-alopecia","journal-title":"Int J Med Rev Case Rep"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2011.05.026","article-title":"A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia","volume":"66","author":"Blume-Peytavi U","year":"2012","unstructured":"Blume-Peytavi U, L\u00f6nnfors S, Hillmann K, Garcia Bartels N. A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia. J Am Acad Dermatol. 2012, 66:794-800. 10.1016\/j.jaad.2011.05.026","journal-title":"J Am Acad Dermatol"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2017.1341610","article-title":"A preliminary study on topical cetirizine in the therapeutic management of androgenetic alopecia","volume":"29","author":"Rossi A","year":"2018","unstructured":"Rossi A, Campo D, Fortuna MC, et al.. A preliminary study on topical cetirizine in the therapeutic management of androgenetic alopecia. J Dermatolog Treat. 2018, 29:149-51. 10.1080\/09546634.2017.1341610","journal-title":"J Dermatolog Treat"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S319676","article-title":"Setipiprant for androgenetic alopecia in males: results from a randomized, double-blind, placebo-controlled phase 2a trial","volume":"14","author":"DuBois J","year":"2021","unstructured":"DuBois J, Bruce S, Stewart D, et al.. Setipiprant for androgenetic alopecia in males: results from a randomized, double-blind, placebo-controlled phase 2a trial. Clin Cosmet Investig Dermatol. 2021, 14:1507-17. 10.2147\/CCID.S319676","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.02.054","article-title":"The effectiveness of treatments for androgenetic alopecia: a systematic review and meta-analysis","volume":"77","author":"Adil A","year":"2017","unstructured":"Adil A, Godwin M. The effectiveness of treatments for androgenetic alopecia: a systematic review and meta-analysis. J Am Acad Dermatol. 2017, 77:136-141.e5. 10.1016\/j.jaad.2017.02.054","journal-title":"J Am Acad Dermatol"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2021.08.013","article-title":"Lasers, lights, and compounds for hair loss in aesthetics","volume":"40","author":"Ring CM","year":"2022","unstructured":"Ring CM, Finney R, Avram M. Lasers, lights, and compounds for hair loss in aesthetics. Clin Dermatol. 2022, 40:64-75. 10.1016\/j.clindermatol.2021.08.013","journal-title":"Clin Dermatol"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.36849\/JDD.6750","article-title":"Evaluating the efficacy of platelet rich plasma and 1550 nm fractional laser in combination and alone for the management of androgenetic alopecia","volume":"21","author":"Haddad N","year":"2022","unstructured":"Haddad N, Arruda S, Swearingen A, Forouzan E, Sadick N. Evaluating the efficacy of platelet rich plasma and 1550 nm fractional laser in combination and alone for the management of androgenetic alopecia. J Drugs Dermatol. 2022, 21:1166-9. 10.36849\/JDD.6750","journal-title":"J Drugs Dermatol"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1016\/j.cps.2022.12.015","article-title":"Noninvasive hair rejuvenation","volume":"50","author":"Sand J","year":"2023","unstructured":"Sand J, Walen S. Noninvasive hair rejuvenation. Clin Plast Surg. 2023, 50:509-20. 10.1016\/j.cps.2022.12.015","journal-title":"Clin Plast Surg"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1159\/000534196","article-title":"Relative effects of minoxidil 5%, platelet-rich plasma, and microneedling in pattern hair loss: a systematic review and network meta-analysis","volume":"9","author":"Gupta AK","year":"2023","unstructured":"Gupta AK, Wang T, Bamimore MA, Polla Ravi S, Talukder M. Relative effects of minoxidil 5%, platelet-rich plasma, and microneedling in pattern hair loss: a systematic review and network meta-analysis. Skin Appendage Disord. 2023, 9:397-406. 10.1159\/000534196","journal-title":"Skin Appendage Disord"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2020.1797676","article-title":"A randomized blinded retrospective study: the combined use of micro-needling technique, low-level laser therapy and autologous non-activated platelet-rich plasma improves hair re-growth in patients with androgenic alopecia","volume":"20","author":"Gentile P","year":"2020","unstructured":"Gentile P, Dionisi L, Pizzicannella J, de Angelis B, de Fazio D, Garcovich S. A randomized blinded retrospective study: the combined use of micro-needling technique, low-level laser therapy and autologous non-activated platelet-rich plasma improves hair re-growth in patients with androgenic alopecia. Expert Opin Biol Ther. 2020, 20:1099-109. 10.1080\/14712598.2020.1797676","journal-title":"Expert Opin Biol Ther"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2023.2245084","article-title":"Systematic review of mesotherapy: a novel avenue for the treatment of hair loss","volume":"34","author":"Gupta AK","year":"2023","unstructured":"Gupta AK, Polla Ravi S, Wang T, Talukder M, Starace M, Piraccini BM. Systematic review of mesotherapy: a novel avenue for the treatment of hair loss. J Dermatolog Treat. 2023, 34:2245084. 10.1080\/09546634.2023.2245084","journal-title":"J Dermatolog Treat"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.4103\/0974-7753.114700","article-title":"A randomized evaluator blinded study of effect of microneedling in androgenetic alopecia: a pilot study","volume":"5","author":"Dhurat R","year":"2013","unstructured":"Dhurat R, Sukesh M, Avhad G, Dandale A, Pal A, Pund P. A randomized evaluator blinded study of effect of microneedling in androgenetic alopecia: a pilot study. Int J Trichology. 2013, 5:6-11. 10.4103\/0974-7753.114700","journal-title":"Int J Trichology"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.03.124","article-title":"Hair transplantation: basic overview","volume":"85","author":"Jimenez F","year":"2021","unstructured":"Jimenez F, Alam M, Vogel JE, Avram M. Hair transplantation: basic overview. J Am Acad Dermatol. 2021, 85:803-14. 10.1016\/j.jaad.2021.03.124","journal-title":"J Am Acad Dermatol"},{"key":"ref73","article-title":"Hair transplantation","volume":"90","author":"Avram MR","year":"2012","unstructured":"Avram MR. Hair transplantation. Cutis. 2012, 90:317-20.","journal-title":"Cutis"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000002373","article-title":"Old friend or new ally: a comparison of follicular unit transplantation and follicular unit excision methods in hair transplantation","volume":"46","author":"Gupta AK","year":"2020","unstructured":"Gupta AK, Love RP, Harris JA. Old friend or new ally: a comparison of follicular unit transplantation and follicular unit excision methods in hair transplantation. Dermatol Surg. 2020, 46:1078-83. 10.1097\/DSS.0000000000002373","journal-title":"Dermatol Surg"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1007\/s00266-023-03300-7","article-title":"A novel method of intraoperative calculation in follicular unit transplantation: \u2018the sequential strip and FUE method\u2019","volume":"48","author":"Krishnamurthy R","year":"2024","unstructured":"Krishnamurthy R, Jaganathan BK, Rangaswamy R, Jeganathan C. A novel method of intraoperative calculation in follicular unit transplantation: \u2018the sequential strip and FUE method\u2019. Aesthetic Plast Surg. 2024, 48:297-303. 10.1007\/s00266-023-03300-7","journal-title":"Aesthetic Plast Surg"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2021.04.003","article-title":"Hair transplantation and follicular unit extraction","volume":"39","author":"Collins K","year":"2021","unstructured":"Collins K, Avram MR. Hair transplantation and follicular unit extraction. Dermatol Clin. 2021, 39:463-78. 10.1016\/j.det.2021.04.003","journal-title":"Dermatol Clin"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1016\/j.fsc.2020.01.011","article-title":"Robotic hair transplantation","volume":"28","author":"Avram MR","year":"2020","unstructured":"Avram MR, Watkins S. Robotic hair transplantation. Facial Plast Surg Clin North Am. 2020, 28:189-96. 10.1016\/j.fsc.2020.01.011","journal-title":"Facial Plast Surg Clin North Am"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.16554","article-title":"A comparative study on the application of robotic hair restoration technology versus traditional follicular unit excision in male androgenetic alopecia","volume":"23","author":"Zhu Y","year":"2024","unstructured":"Zhu Y, Yang K, Lin JM, et al.. A comparative study on the application of robotic hair restoration technology versus traditional follicular unit excision in male androgenetic alopecia. J Cosmet Dermatol. 2024, 23:4213-22. 10.1111\/jocd.16554","journal-title":"J Cosmet Dermatol"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjps.2006.03.041","article-title":"Follicular unit transplantation for male-pattern hair loss: evaluation of 120 patients","volume":"59","author":"Tan Baser N","year":"2006","unstructured":"Tan Baser N, Cigsar B, Balci Akbuga U, Terzioglu A, Aslan G. Follicular unit transplantation for male-pattern hair loss: evaluation of 120 patients. J Plast Reconstr Aesthet Surg. 2006, 59:1162-9. 10.1016\/j.bjps.2006.03.041","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-1771291","article-title":"Hair restoration techniques","volume":"39","author":"Shehan JN","year":"2023","unstructured":"Shehan JN, Spiegel JH. Hair restoration techniques. Facial Plast Surg. 2023, 39:512-6. 10.1055\/s-0043-1771291","journal-title":"Facial Plast Surg"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10537","article-title":"Epidermal \u03b2-catenin activation remodels the dermis via paracrine signalling to distinct fibroblast lineages","volume":"7","author":"Lichtenberger BM","year":"2016","unstructured":"Lichtenberger BM, Mastrogiannaki M, Watt FM. Epidermal \u03b2-catenin activation remodels the dermis via paracrine signalling to distinct fibroblast lineages. Nat Commun. 2016, 7:10537. 10.1038\/ncomms10537","journal-title":"Nat Commun"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.3390\/cells9061344","article-title":"Migration inhibitory factor in conditioned medium from human umbilical cord blood-derived mesenchymal stromal cells stimulates hair growth","volume":"9","author":"Oh HA","year":"2020","unstructured":"Oh HA, Kwak J, Kim BJ, et al.. Migration inhibitory factor in conditioned medium from human umbilical cord blood-derived mesenchymal stromal cells stimulates hair growth. Cells. 2020, 9:1344. 10.3390\/cells9061344","journal-title":"Cells"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.2147\/SCCAA.S131431","article-title":"Hair follicle growth by stromal vascular fraction-enhanced adipose transplantation in baldness","volume":"10","author":"Perez-Meza D","year":"2017","unstructured":"Perez-Meza D, Ziering C, Sforza M, Krishnan G, Ball E, Daniels E. Hair follicle growth by stromal vascular fraction-enhanced adipose transplantation in baldness. Stem Cells Cloning. 2017, 10:1-10. 10.2147\/SCCAA.S131431","journal-title":"Stem Cells Cloning"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1016\/j.reth.2022.05.008","article-title":"Current regenerative medicine-based approaches for skin regeneration: a review of literature and a report on clinical applications in Japan","volume":"21","author":"Shimizu Y","year":"2022","unstructured":"Shimizu Y, Ntege EH, Sunami H. Current regenerative medicine-based approaches for skin regeneration: a review of literature and a report on clinical applications in Japan. Regen Ther. 2022, 21:73-80. 10.1016\/j.reth.2022.05.008","journal-title":"Regen Ther"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1038\/srep05432","article-title":"Treatment of MSCs with Wnt1a-conditioned medium activates DP cells and promotes hair follicle regrowth","volume":"4","author":"Dong L","year":"2014","unstructured":"Dong L, Hao H, Xia L, et al.. Treatment of MSCs with Wnt1a-conditioned medium activates DP cells and promotes hair follicle regrowth. Sci Rep. 2014, 4:5432. 10.1038\/srep05432","journal-title":"Sci Rep"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2016.1227419","article-title":"Stem cell therapy as a novel therapeutic intervention for resistant cases of alopecia areata and androgenetic alopecia","volume":"29","author":"Elmaadawi IH","year":"2018","unstructured":"Elmaadawi IH, Mohamed BM, Ibrahim ZA, et al.. Stem cell therapy as a novel therapeutic intervention for resistant cases of alopecia areata and androgenetic alopecia. J Dermatolog Treat. 2018, 29:431-40. 10.1080\/09546634.2016.1227419","journal-title":"J Dermatolog Treat"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/342487-comprehensive-review-on-hair-loss-and-restorative-techniques-advances-in-diagnostic-artistry-and-surgical-innovation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T16:57:37Z","timestamp":1745600257000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/342487-comprehensive-review-on-hair-loss-and-restorative-techniques-advances-in-diagnostic-artistry-and-surgical-innovation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":86,"URL":"https:\/\/doi.org\/10.7759\/cureus.82991","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,25]]}}}